Shayan Mohammadmoradi: Why Cardiovascular Research in Kentucky Is More Than Just Publishing Papers
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared on LinkedIn:
“In my recent op-ed, I reflect on why doing this work here in Kentucky carries urgency and responsibility.
Every discovery has the potential to directly impact the people around us.
At the University of Kentucky College of Medicine, we are uniquely positioned at the forefront of cardiovascular research.
Through centers like the Cardiovascular Research Center and the Barnstable Brown Diabetes and Obesity Center, and Gill Heart and Vascular Institur UK integrates basic science, translational research, and clinical care under one roof.
That proximity, lab to clinic to community, accelerates impact in ways few institutions can.
As a scientist and volunteer leader with American Heart Association, I also see how national advocacy, research funding, and community engagement amplify what we do locally.
Science, policy, and prevention must move together.
Cardiovascular research in Kentucky is not just about publishing papers.
It is about responsibility.
It is about regional leadership.
It is about changing outcomes where the need is greatest.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:30José Luis Neyro: E4 and DRSP Reduce Hirsutism While Showing Comparable Effects on Thrombin Generation
-
Aug 15, 2026, 19:27Mahmoud Akraym: Don’t Choose Anticoagulation as the Immediate Treatment for Unstable AF
-
Aug 15, 2026, 19:25Ahmed Bennis: DOACs Increase 1-Year Stroke Risk but Reduce MI Risk Compared With Warfarin
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis